https://www.selleckchem.com/pr....oducts/2-aminoethyl-
0001) and IPF ( p = 0.0004) than CAD patients. Conclusion ET patients have lower 24-hour antiplatelet effect of aspirin than CAD patients. This may be explained by an increased platelet production and turnover counteracting the antiplatelet effect of aspirin. These findings strengthen the rationale for exploring novel antiplatelet regimens in ET patients to reduce the risk of cardiovascular events.Fractures, especially if articular and periarticular, are frequently associated to functional and clinical disabling
Like
Comment
Share
